Halberd Daily News Today

Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 189,400 shares, an increase of 272.8% from the January 31st total of 50,800 shares. Based on an average daily volume of 2,811,300 shares, the […]

Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 206,900 shares, a growth of 61.0% from the December 31st total of 128,500 shares. Based on an average daily trading volume, of 6,831,400 shares, the short-interest ratio is presently 0.0 […]

Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 10,600 shares, a growth of 10,500.0% from the July 31st total of 100 shares. Based on an average trading volume of 1,340,900 shares, the days-to-cover ratio is […]

Halberd (OTCMKTS:HALB – Get Free Report) is one of 385 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Halberd to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Valuation & Earnings This table compares […]

Halberd (OTCMKTS:HALB – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to similar companies based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, earnings and risk. Profitability This table compares Halberd and its peers’ net […]

Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings. Insider & Institutional Ownership 22.1% of shares of all […]

Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends. Institutional and Insider Ownership 22.1% of shares […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, profitability, valuation, risk, earnings, dividends and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its profitability, earnings, risk, analyst recommendations, dividends, valuation and institutional ownership. Earnings and Valuation This table compares Halberd […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 371 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, earnings, profitability and valuation. Profitability This table compares Halberd and its competitors’ net […]